Reuters logo
BRIEF-Marathon Pharmaceuticals Llc CEO says on CureDuchenne - pausing launch of EMFLAZA
February 13, 2017 / 10:04 PM / 10 months ago

BRIEF-Marathon Pharmaceuticals Llc CEO says on CureDuchenne - pausing launch of EMFLAZA

Feb 13 (Reuters) -

* Marathon Pharmaceuticals Llc CEO says on CureDuchenne blog - pausing launch of EMFLAZA; says will maintain expanded access program Source text : bit.ly/2lDiGsN

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below